NUV-1511 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03 (month) in 4mo
ESTIMATED |
READOUT
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumo
Phase 1/2 · Advanced Solid Tumor, HER2-negative Breast Cancer |
NUVB Nuvation Bio Inc. | NUV-1511 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
|